Deconstructing protein and gene expression pathways to define the anticancer effects of XPO1 inhibition in ovarian cancer

被引：0
|
作者：
Evans, Brad R. [1 ]
Silvers, Thomas R. [1 ]
Chen, Ying A. [1 ]
Garcia, Jason [1 ]
Camacho, Catalina [1 ]
Sharp, Andrew J. [1 ]
Garag, Paras [1 ]
Koduru, Srinivas V. [2 ]
Billaud, Jean-Noel [3 ]
Halpert, Richard L. [3 ]
Dottino, Peter R. [1 ]
Landesman, Yosef [4 ]
Shacham, Sharon [4 ]
Martignetti, John A. [1 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Gene Arrays, New York, NY USA
[3] Qiagen Bioinformat, Redwood City, CA USA
[4] Karyopharm Therapeut Inc, Natick, MA USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-1758
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1758
引用
收藏
页数：2
相关论文
共 50 条
  • [21] XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expression
    Fisher, Jack G.
    Doyle, Amber D. P.
    Graham, Lara V.
    Sonar, Shreyanshi
    Sale, Ben
    Henderson, Isla
    Del Rio, Luis
    Johnson, Peter W. M.
    Landesman, Yosef
    Cragg, Mark S.
    Forconi, Francesco
    Walker, Christopher J.
    Khakoo, Salim. I.
    Blunt, Matthew D.
    LEUKEMIA, 2023, 37 (10) : 2036 - 2049
  • [22] Inhibition of nuclear transport protein XPO1 potentiates the effect of KRAS G12C inhibitors.
    Khan, Husain Y.
    Uddin, Md. Hafiz
    Zhang, Yue
    Landesman, Yosef
    Sukari, Ammar
    Nagasaka, Misako
    Azmi, Asfar S.
    CANCER RESEARCH, 2021, 81 (13)
  • [23] Anticancer drugs induce mdr1 gene expression in recurrent ovarian cancer
    Hille, Stephanie
    Rein, Daniel T.
    Riffelmann, Marion
    Neumann, Rainer
    Sartorius, Judith
    Pfuetzner, Andreas
    Kurbacher, Christian M.
    Schoendorf, Thomas
    Breidenbach, Martina
    ANTI-CANCER DRUGS, 2006, 17 (09) : 1041 - 1044
  • [24] XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expression
    Jack G. Fisher
    Amber D. P. Doyle
    Lara V. Graham
    Shreyanshi Sonar
    Ben Sale
    Isla Henderson
    Luis Del Rio
    Peter W. M. Johnson
    Yosef Landesman
    Mark S. Cragg
    Francesco Forconi
    Christopher J. Walker
    Salim. I. Khakoo
    Matthew D. Blunt
    Leukemia, 2023, 37 : 2036 - 2049
  • [25] Effect of XPO1 inhibition in cancer cells on the 3D nuclear organization of telomeres: Quantitative analysis of short-term effects
    Lichtensztejn, Daniel
    Cheang, Mary
    Baloglu, Erkan
    Senapedis, William
    Shacham, Sharon
    Kauffman, Michael
    Mai, Sabine
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [26] Down-regulation of AR splice variants through XPO1 suppression contributes to the inhibition of prostate cancer progression
    Muqbil, Irfana
    Li, Yiwei
    Baloglu, Erkan
    Senapedis, William
    Landesman, Yosef
    Argueta, Christian
    Kauffman, Michael
    Friedlander, Sharon
    Chang, Hua
    Shacham, Sharon
    Heath, Elisabeth
    Azmi, Asfar S.
    CANCER RESEARCH, 2018, 78 (13)
  • [27] Expression and antisense inhibition of c-raf-1 protein in ovarian cancer
    Mullen, P
    McPhillips, F
    Monia, BP
    Smyth, JF
    Langdon, SP
    BRITISH JOURNAL OF CANCER, 1999, 80 : 23 - 23
  • [28] XPO1 inhibition strongly sensitizes to first-line and second-line therapy in small cell lung cancer
    Quintanal-Villalonga, A.
    Taniguchi, H.
    Hao, Y.
    Chow, A.
    Zhan, Y. A.
    Uddin, F.
    Allaj, V.
    Manoj, P.
    Shah, N.
    Chan, J. M.
    Offin, M.
    Ciampricotti, M.
    Egger, J.
    Qiu, J.
    De Stanchina, E.
    Hollmann, T. J.
    Koche, R. P.
    Sen, T.
    Poirier, J. T.
    Rudin, C. M.
    ANNALS OF ONCOLOGY, 2021, 32 : S1345 - S1345
  • [29] Lost expression of DCC gene in ovarian cancer and its inhibition in ovarian cancer cells
    Liu Meimei
    Li Peiling
    Li Baoxin
    Li Changmin
    Zhuang Rujin
    Hu Chunjie
    MEDICAL ONCOLOGY, 2011, 28 (01) : 282 - 289
  • [30] Lost expression of DCC gene in ovarian cancer and its inhibition in ovarian cancer cells
    Liu Meimei
    Li Peiling
    Li Baoxin
    Li Changmin
    Zhuang Rujin
    Hu Chunjie
    Medical Oncology, 2011, 28 : 282 - 289
12345